Status:
TERMINATED
Treatment of Neurogenic Incontinence by Surgery to Cut the Filum Terminale
Lead Sponsor:
Nemours Children's Clinic
Conditions:
Neurogenic Incontinence
Dysfunctional Voiding
Eligibility:
All Genders
5-16 years
Brief Summary
The target population of this study is children with primary or secondary daytime urinary incontinence, who have failed to improve adequately despite compliance with at least 6 months of standard medi...
Eligibility Criteria
Inclusion
- Primary or secondary daytime urinary incontinence, persistent over at least 6 months of medical treatment.
- Abnormal urodynamic testing
- Normal conus on magnetic resonance imaging of the spine
- Dysfunctional Voiding Symptom Scale score greater than 6 for girls or greater than 9 for boys
Exclusion
- Bladder outlet obstruction
- Bladder atony
- Congenital anorectal malformation
- Additional diagnoses independently associated with neurogenic bladder dysfunction
- Encephalopathy precluding reasonable expectation of attainment of continence
- Inability to comply with medical management
- Unwillingness to comply with initial or follow up urodynamic testing
Key Trial Info
Start Date :
July 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2014
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT01465581
Start Date
July 1 2011
End Date
April 1 2014
Last Update
April 17 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
A I duPont Hospital for Children
Wilmington, Delaware, United States, 19803